Pfizer just raised its dividend by 2.4% to $0.43, giving investors something to cheer about despite the stock’s lackluster ...

Pfizer's shares have significantly underperformed, but the current valuation and high dividend yield present a compelling ...

Pfizer Inc.'s ( NYSE:PFE) periodic dividend will be increasing on the 7th of March to $0.43, with investors receiving 2.4% ...

With a market capitalization of more than $143 billion today, Pfizer (NYSE: PFE) stock won't make anyone into a millionaire ...

CHARLESTON, W.Va. — West Virginia Attorney General Patrick Morrisey on Thursday said the Circuit Court of Mason County has approved a settlement between the state and pharmaceutical companies Pfizer ...

The efficacy data could help cushion Ibrance's losses of market share to Kisqali, a similar drug from Novartis.

SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a ...

Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

Executives from Pfizer Inc and Amazon.com see opportunities for working with U.S. health secretary nominee Robert F. Kennedy ...

Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared an increase in the quarterly cash dividend on ...

Ibuzatrelvir is a small molecule commercialized by Pfizer, with a leading Phase II program in Coronavirus Disease 2019 (COVID-19).

Today, Benzinga 's options scanner spotted 29 uncommon options trades for Pfizer. This isn't normal. The overall sentiment of ...